KLK3 and cancer: PSA, a serine protease, is a prostate-specific antigen, but not a prostate-cancer-specific antigen [4]; thus, the test (with a cut-off point of >4 ng/mL) cannot accurately predict the malignancy of this cancer and fails to distinguish indolent cancer from aggressive cancer.